Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis

NCT03066869 is registered in ClinicalTrials.gov with Ocular Immunology and Uveitis Foundation as lead sponsor.

NCT NCT03066869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03066869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Lead sponsor
Ocular Immunology and Uveitis Foundation
Phase
Phase 4
Overall status
Unknown status
Start date
March 22, 2017
Completion date
August 31, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis, posterior, vasculitis retinal